Supplemental Annuity Collective Trust Of Nj Xenon Pharmaceuticals Inc. Put Options Transaction History
Supplemental Annuity Collective Trust Of Nj
- $348 Million
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding XENE
# of Institutions
224Shares Held
71.1MCall Options Held
435KPut Options Held
207K-
Avoro Capital Advisors LLC New York, NY5.74MShares$192 Million3.12% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.58MShares$153 Million1.68% of portfolio
-
Wellington Management Group LLP Boston, MA3.79MShares$127 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X03.33MShares$111 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA3.09MShares$103 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.08B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...